According to researchers, the adapted treatment could help to prevent muscle damage and permanent physical impacts.

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

A new study shows mRNA-based treatment can protect muscle tissue from snake venom damage, offering a potential boost to ...

The success of mRNA technology and its potential uses in therapeutics and preventative medical treatment may create a new technology ecosystem, the Harvard Business Review reported April 18. As has ...

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the blueprint for functional proteins in the body and induces therapeutic effects.

The market for mRNA vaccines has experienced a surge fueled by the global rollout of the COVID-19 vaccines, and the potential of mRNA technology in public health opens a new frontier in medical ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase III trial that will test out a vaccine against norovirus, a frequent and ...